Seeger Weiss Partner Christopher Ayers Appointed Co-Lead Class Counsel in Band-Aid PFAS Litigation

Ayers will advocate for consumers in lawsuit alleging Johnson & Johnson and Kenvue’s Band-Aid products contain dangerous “forever chemicals”.

January 23, 2025

Chris Ayers Band-Aid Graphic

RIDGEFIELD PARK, NJ – Seeger Weiss partner Christopher L. Ayers has been appointed Interim Co-Lead Class Counsel in the Band-Aid PFAS litigation by the Honorable Judge Michael A. Shipp of the District of New Jersey. The litigation consolidates multiple class action lawsuits alleging that Johnson & Johnson and its spin-off company Kenvue Inc. sold Band-Aid brand adhesive bandages containing unsafe levels of per- and polyfluoroalkyl substances (PFAS) chemicals while failing to disclose their presence to consumers.

PFAS are synthetic “forever chemicals” known for their persistence in the environment and human body. Testing has revealed detectable levels of PFAS in Band-Aid products, including the OURTONE line which features a variety of Black and Brown skin tones marketed to people of color. The lawsuits allege that defendants marketed Band-Aids as safe and high-quality while knowingly selling products containing dangerous PFAS chemicals without disclosing their presence.

“I am honored to serve as co-lead counsel in this important consumer protection case,” said Ayers. “For generations, millions of Americans have trusted Band-Aid products, applying them directly to injuries without knowing they contain forever chemicals that can be absorbed into the body. We are committed to holding Johnson & Johnson and Kenvue accountable for concealing the presence of these dangerous chemicals in their products and will work to ensure consumers have transparency about products they trust with their families’ health.”

A partner at Seeger Weiss, Christopher Ayers is an experienced trial attorney representing individual and corporate plaintiffs in complex litigation nationwide. He currently serves on the Plaintiffs’ Executive Committee and Co-Chair of the E-Discovery Committee in the Social Media Adolescent Addiction/Personal Injury Litigation and represents the Estate of Henrietta Lacks and members of her family seeking justice against pharmaceutical and biotechnology companies for unjustly profiting off Mrs. Lacks’s stolen cells. His practice focuses on class actions, mass torts, and complex commercial litigation involving consumer protection, product liability, and corporate misconduct.

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More